
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Hydrocelin
Therapeutic Area : Musculoskeletal
Study Phase : Preclinical
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Allegro’s Injectable Osteoarthritis Treatment Shows Positive Safety Data
Details : ALG-001 (hydrocelin), is an injectable microparticle hydrogel, which is currently being evaluated for the treatment of patients with osteoarthritis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 25, 2025
Lead Product(s) : Hydrocelin
Therapeutic Area : Musculoskeletal
Highest Development Status : Preclinical
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Hydrocelin
Therapeutic Area : Musculoskeletal
Study Phase : Preclinical
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Allegro Reports Positive Safety Data for its Injectable Osteoarthritis Treatment
Details : ALG-001 (hydrocelin) is an injectable microparticle hydrogel designed as a potential disease-modifying treatment for osteoarthritis. It is being evaluated in preclinical studies.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 04, 2025
Lead Product(s) : Hydrocelin
Therapeutic Area : Musculoskeletal
Highest Development Status : Preclinical
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
